<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01877447</url>
  </required_header>
  <id_info>
    <org_study_id>aF3_cF4_F32</org_study_id>
    <nct_id>NCT01877447</nct_id>
  </id_info>
  <brief_title>Comparison of Two tDCS Protocols for the Treatment of Major Depressive Disorder</brief_title>
  <official_title>Comparison of Two Transcranial Direct Current Stimulation (tDCS) Protocols for the Treatment of Major Depressive Disorder: a Randomized, Double-blinded, Controlled Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Transcranial direct cranial stimulation (tDCS) is a novel technique based on the application
      of a weak electrical current over the scalp through two electrodes - the anode, which
      facilitates neuronal depolarization, and the cathode, which leads to neuronal
      hyper-polarization. Recently, several open-label and sham-controlled clinical trials applied
      daily tDCS sessions for the treatment of major depressive disorder (MDD). Theoretically, tDCS
      displays depression improvement through anodal stimulation over the left dorsolateral
      prefrontal, inducing excitability-enhancing effects over this area, which is hypoactive
      during the acute depressive episode. The present study is aimed at comparing two different
      tDCS protocols: (1) active anodic stimulation over left dorsolateral prefrontal cortex with
      cathode placed over an extra cephalic area; (2) active cathode placed over the right
      dorsolateral prefrontal cortex with anode placed over an extra cephalic area.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The present research protocol will evaluate clinical effects of two different tDCS protocols:
      (1) active anodic stimulation over left dorsolateral prefrontal cortex with cathode placed
      over an extra cephalic area; (2) active cathode placed over the right dorsolateral prefrontal
      cortex with anode placed over an extra cephalic area. Patients will be clinically evaluated
      with the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV)
      criteria for depression. Symptoms intensity will be rated according to The Hamilton
      Depression Scale (HAMD -17 items) - main outcome. Patients with scores higher than 16 will be
      included. Patients with active neurological or severe disorders (such as cancer or auto-imune
      disorders) will be excluded. The present study is a double-blinded, controlled, randomized
      trial with 30 patients with depression. The intervention protocol consist in 15 consecutive
      daily tDCS sessions (skipping the weekend). After meeting eligibility criteria, patients will
      be randomized (computer generated list) to one of the two intervention groups. We will use a
      direct current of 2.0 milliamperes (mA) for 30 min. The 35 cm2-rubber electrodes will be
      wrapped in cotton material, which should be moistened with saline as to reduce impedance.
      Patients will be clinically assessed at baseline and at end of 6 weeks. Main outcome will be
      based on HAMD-17 items at a final endpoint of 6-weeks, with secondary outcomes assessing Beck
      Depression Inventory (21 items) at 6 weeks. Other evaluation scales include Beck Anxiety
      Inventory, Hamilton Anxiety Scale and Safety and cognitive assessment will be performed with
      The Montreal Cognitive Assessment, adverse effects scales and clinical evaluation with a
      trained physician.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hamilton Rating Scale for Depression, 17 items (HAMD17)</measure>
    <time_frame>Weeks 0, 3 and 6</time_frame>
    <description>reduction of depressive symptoms as assessed by HAMD17</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Montgomery-Asberg Depression Rating Scale (MADRS)</measure>
    <time_frame>Weeks 0, 3 and 6</time_frame>
    <description>reduction of depressive symptoms as assessed by MADRS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Depression Inventory (BDI)</measure>
    <time_frame>Weeks 0, 3 and 6</time_frame>
    <description>reduction of depressive symptoms as assessed by BDI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Anxiety Inventory (BAI)</measure>
    <time_frame>Weeks 0, 3 and 6</time_frame>
    <description>reduction of anxiety symptoms as assessed by BAI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hamilton Anxiety Inventory (HAI)</measure>
    <time_frame>Weeks 0, 3 and 6</time_frame>
    <description>reduction of anxiety symptoms as assessed by HAI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Montreal Cognitive Assessment (Moca)</measure>
    <time_frame>Weeks 0 and 6</time_frame>
    <description>evaluate cognitive stability as assessed by Moca</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>MAjor Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>cathodal F4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transcranial Direct Current Stimulation
Cathodal tDCS over F4 (right dorsolateral prefrontal cortex) Anodal tDCS over the left deltoid (extra-cephalic) n=15</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Anodal F3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transcranial Direct Current Stimulation'
Anodal tDCS over F3 (right dorsolateral prefrontal cortex) Cathodal tDCS over the right deltoid (extra-cephalic) n=15</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Direct Current Stimulation</intervention_name>
    <description>Current Stimulation with cathodal stimulation over right dorsolateral prefrontal cortex. Anodal stimulation over left deltoid region</description>
    <arm_group_label>cathodal F4</arm_group_label>
    <arm_group_label>Anodal F3</arm_group_label>
    <other_name>tDCS</other_name>
    <other_name>Brain polarization</other_name>
    <other_name>Brain stimulation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with age between 18-89 years, depression diagnosis according to Diagnostic
             and Statistical Manual of Mental Disorders Fourth Edition (DSM-iV); HAMD scores higher
             than 16; accordance to inform consent

        Exclusion Criteria:

          -  active neurologic or severe disorder (such as cancer or auto-imune)

          -  pregnancy;

          -  need for hospitalization
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andre R Brunoni, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Center of Clinical Research - Hospital Universitário USP; Sao Paulo; Brazil</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitário - USP</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05508000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Brunoni AR, Kemp AH, Shiozawa P, Cordeiro Q, Valiengo LC, Goulart AC, Coprerski B, Lotufo PA, Brunoni D, Perez AB, Fregni F, Benseñor IM. Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: implications for the serotonergic system. Eur Neuropsychopharmacol. 2013 Nov;23(11):1530-40. doi: 10.1016/j.euroneuro.2013.03.009. Epub 2013 Apr 21.</citation>
    <PMID>23615118</PMID>
  </reference>
  <reference>
    <citation>Brunoni AR, Benute GR, Fráguas R, Santos NO, Francisco RP, de Lucia MC, Zugaib M. The self-rated Inventory of Depressive Symptomatology for screening prenatal depression. Int J Gynaecol Obstet. 2013 Jun;121(3):243-6. doi: 10.1016/j.ijgo.2013.01.011. Epub 2013 Mar 15.</citation>
    <PMID>23499135</PMID>
  </reference>
  <reference>
    <citation>Kalu UG, Sexton CE, Loo CK, Ebmeier KP. Transcranial direct current stimulation in the treatment of major depression: a meta-analysis. Psychol Med. 2012 Sep;42(9):1791-800. doi: 10.1017/S0033291711003059. Epub 2012 Jan 12. Review.</citation>
    <PMID>22236735</PMID>
  </reference>
  <reference>
    <citation>Brunoni AR, Valiengo L, Baccaro A, Zanão TA, de Oliveira JF, Goulart A, Boggio PS, Lotufo PA, Benseñor IM, Fregni F. The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial. JAMA Psychiatry. 2013 Apr;70(4):383-91. doi: 10.1001/2013.jamapsychiatry.32.</citation>
    <PMID>23389323</PMID>
  </reference>
  <reference>
    <citation>Brunoni AR, Ferrucci R, Fregni F, Boggio PS, Priori A. Transcranial direct current stimulation for the treatment of major depressive disorder: a summary of preclinical, clinical and translational findings. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Oct 1;39(1):9-16. doi: 10.1016/j.pnpbp.2012.05.016. Epub 2012 May 28. Review.</citation>
    <PMID>22651961</PMID>
  </reference>
  <reference>
    <citation>Brunoni AR, Ferrucci R, Bortolomasi M, Vergari M, Tadini L, Boggio PS, Giacopuzzi M, Barbieri S, Priori A. Transcranial direct current stimulation (tDCS) in unipolar vs. bipolar depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jan 15;35(1):96-101. doi: 10.1016/j.pnpbp.2010.09.010. Epub 2010 Sep 18.</citation>
    <PMID>20854868</PMID>
  </reference>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 24, 2013</study_first_submitted>
  <study_first_submitted_qc>June 10, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 13, 2013</study_first_posted>
  <last_update_submitted>December 13, 2013</last_update_submitted>
  <last_update_submitted_qc>December 13, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Andre Brunoni</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>tDCS</keyword>
  <keyword>Brain stimulation</keyword>
  <keyword>depressive disorder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

